Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Sarcoma × Ferrosoferric Oxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Cancer, Papillary 1 Sarcoma 1 Pancreatic carcinoma, familial 1 Pancreatic Intraductal Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Medullary 1 Cancer of Lymph Node 1 Brain Neoplasms 1 Adult Brain Glioblastoma 1

Interventions

Ifosfamide 7 Doxorubicin 7 Blood Specimen Collection 7 Radiosurgery 6 Surveys and Questionnaires 4 Standard of Care 4 Radiotherapy 4 Proton Therapy 4 X-Rays 3 Vincristine 3 Surgical Procedures, Operative 3 Radiation Dose Hypofractionation 3 Methods 3 Mesna 3 Magnetic Resonance Spectroscopy 3 pegfilgrastim 2 pazopanib 2 dexamethasone acetate 2 Trastuzumab 2 Transurethral Resection of Bladder 2 Restraint, Physical 2 Radiotherapy, Intensity-Modulated 2 Practice Guidelines as Topic 2 Palliative Care 2 Melphalan 2 Heavy Ion Radiotherapy 2 Gene Expression Profiling 2 Exercise 2 Etoposide 2 Enhanced Recovery After Surgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01663090 2020-10-19

Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas

Dana-Farber Cancer Institute

Phase NA Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡